News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
578,606 Results
Type
Article (41832)
Company Profile (122)
Press Release (536644)
Multimedia
Podcasts (86)
Webinars (18)
Section
Business (155448)
Career Advice (2459)
Deals (28288)
Drug Delivery (122)
Drug Development (73825)
Employer Resources (141)
FDA (13982)
Job Trends (12440)
News (276649)
Policy (27372)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2592)
Academic (1)
Accelerated approval (41)
Adcomms (30)
Allergies (159)
Alliances (39340)
ALS (191)
Alzheimer's disease (1756)
Antibody-drug conjugate (ADC) (386)
Approvals (14277)
Artificial intelligence (569)
Autoimmune disease (218)
Automation (44)
Bankruptcy (314)
Best Places to Work (10077)
BIOSECURE Act (17)
Biosimilars (188)
Biotechnology (89)
Bladder cancer (175)
Brain cancer (63)
Breast cancer (657)
Cancer (5184)
Cardiovascular disease (452)
Career advice (2088)
Career pathing (41)
CAR-T (283)
CDC (55)
Cell therapy (764)
Cervical cancer (35)
Clinical research (64061)
Collaboration (1721)
Company closure (5)
Compensation (744)
Complete response letters (79)
COVID-19 (2620)
CRISPR (92)
C-suite (1056)
Cystic fibrosis (129)
Data (6931)
Decentralized trials (3)
Denatured (17)
Depression (163)
Dermatology (67)
Diabetes (533)
Diagnostics (6245)
Digital health (43)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (267)
Drug pricing (186)
Drug shortages (27)
Duchenne muscular dystrophy (273)
Earnings (59826)
Editorial (60)
Employer branding (18)
Employer resources (133)
Events (81708)
Executive appointments (1056)
FDA (17225)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1459)
Gene editing (203)
Generative AI (54)
Gene therapy (659)
GLP-1 (1013)
Government (4431)
Grass and pollen (7)
Guidances (395)
Healthcare (16246)
HIV (73)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (293)
Immuno-oncology (85)
Indications (151)
Infectious disease (2932)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (124)
Intellectual property (260)
Interviews (527)
IPO (12873)
IRA (53)
Job creations (2666)
Job search strategy (1681)
JPM (56)
Kidney cancer (20)
Labor market (65)
Layoffs (523)
Leadership (41)
Legal (5837)
Liver cancer (98)
Longevity (24)
Lung cancer (724)
Lymphoma (395)
Machine learning (46)
Management (51)
Manufacturing (809)
MASH (195)
Medical device (11032)
Medtech (11098)
Mergers & acquisitions (16467)
Metabolic disorders (1405)
mRNA (164)
Multiple sclerosis (175)
NASH (24)
Neurodegenerative disease (392)
Neuropsychiatric disorders (105)
Neuroscience (3168)
Neurotech (1)
NextGen: Class of 2026 (5600)
Non-profit (4047)
Now hiring (63)
Obesity (648)
Opinion (288)
Ovarian cancer (189)
Pain (225)
Pancreatic cancer (257)
Parkinson's disease (338)
Partnered (30)
Patents (532)
Patient recruitment (593)
Peanut (53)
People (53644)
Pharmaceutical (22)
Pharmacy benefit managers (19)
Phase 1 (19756)
Phase 2 (28172)
Phase 3 (21430)
Pipeline (7081)
Policy (303)
Postmarket research (2322)
Preclinical (8108)
Press Release (54)
Prostate cancer (264)
Psychedelics (56)
Radiopharmaceuticals (271)
Rare diseases (986)
Real estate (4277)
Recruiting (60)
Regulatory (21845)
Reports (31)
Research institute (2213)
Resumes & cover letters (360)
Rett syndrome (32)
RNA editing (20)
RSV (78)
Schizophrenia (172)
Series A (244)
Series B (182)
Service/supplier (5)
Sickle cell disease (104)
Special edition (20)
Spinal muscular atrophy (163)
Sponsored (41)
Startups (2919)
State (2)
Stomach cancer (19)
Supply chain (105)
Tariffs (76)
The Weekly (67)
Vaccines (1002)
Venture capital (96)
Weight loss (431)
Women's health (91)
Worklife (20)
Date
Today (117)
Last 7 days (517)
Last 30 days (2345)
Last 365 days (26817)
2026 (7920)
2025 (26911)
2024 (30998)
2023 (34630)
2022 (45136)
2021 (48434)
2020 (46827)
2019 (39981)
2018 (30319)
2017 (27290)
2016 (25987)
2015 (30370)
2014 (22848)
2013 (18610)
2012 (19996)
2011 (20936)
2010 (18531)
Location
Africa (745)
Alabama (83)
Alaska (4)
Arizona (241)
Arkansas (12)
Asia (35505)
Australia (7365)
California (10518)
Canada (3267)
China (1177)
Colorado (450)
Connecticut (433)
Delaware (342)
Europe (79781)
Florida (1684)
Georgia (335)
Hawaii (3)
Idaho (54)
Illinois (866)
India (77)
Indiana (517)
Iowa (17)
Japan (466)
Kansas (121)
Kentucky (35)
Louisiana (36)
Maine (59)
Maryland (1311)
Massachusetts (7196)
Michigan (304)
Minnesota (524)
Mississippi (5)
Missouri (131)
Montana (26)
Nebraska (25)
Nevada (124)
New Hampshire (80)
New Jersey (2985)
New Mexico (21)
New York (2814)
North Carolina (1316)
North Dakota (6)
Northern California (5191)
Ohio (315)
Oklahoma (13)
Oregon (33)
Pennsylvania (2161)
Puerto Rico (27)
Rhode Island (40)
South America (1006)
South Carolina (75)
South Dakota (2)
Southern California (4202)
Tennessee (167)
Texas (1769)
United States (37506)
Utah (344)
Vermont (1)
Virginia (261)
Washington D.C. (66)
Washington State (882)
West Virginia (4)
Wisconsin (98)
Wyoming (2)
578,606 Results for "proclara biosciences formerly known as neurophage".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 30, 2026
·
19 min read
Press Releases
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
April 15, 2026
·
5 min read
Press Releases
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
April 13, 2026
·
4 min read
Press Releases
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 9, 2026
·
8 min read
Press Releases
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines
February 25, 2026
·
4 min read
Press Releases
Imbed Biosciences Announces CMS Assignment of HCPCS Code A2040 for Microlyte® PainGuard™
April 2, 2026
·
2 min read
Press Releases
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data
February 19, 2026
·
6 min read
Press Releases
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
April 16, 2026
·
5 min read
Press Releases
Precision BioSciences Announces Presentation at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
February 18, 2026
·
5 min read
Press Releases
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
March 20, 2026
·
8 min read
1 of 57,861
Next
